0
Article |

Inhalational vs Oral Steroid Therapy in Childhood Asthma FREE

LILLIAN P. KRAVIS, MD; HAROLD I. LECKS, MD
[+] Author Affiliations

Received for publication Sept 2, 1965.

Reprint requests to 225 Old Lancaster Rd, Bala Cynwyd, Pa (Dr. Kravis).

Data supplied by manufacturer.


Am J Dis Child. 1966;111(4):343-352. doi:10.1001/archpedi.1966.02090070041002.
Text Size: A A A
Published online

PEDIATRIC allergists, numbering, as they invariably do, among their patients a small core of chronically ill, steroid-dependent asthmatic youngsters, have long shown an interest in inhalational steroid therapy, particularly since the adverse effects of long-term oral steroid usage became known. Their hope was that direct application of corticosteroids to the bronchi and subbronchial airways might result in a marked reduction in steroid requirements for this group of patients and, at the same time, might keep systemic absorption to such minimal levels that adrenocortical suppression would not occur. Ultimate weaning off of steroids might thus be facilitated. When a compact aerosol eventually was devised which contained the highly water-soluble dexamethasone-sodium-21-phosphate in a small-particled, relatively tasteless form, it was promptly put to clinical trial in centers in this country and elsewhere where young and old asthmatic patients were under treatment. The purpose of this paper is to summarize the published results of

REFERENCES

Snider, G.L., et al:  Effect of Dexamethasone Aerosol on Airway Obstruction in Bronchial Asthma , Dis Chest 44:408, 1963;.
Toogood, J.F., and Lefcoe, N.M.:  Dexamethasone Aerosol for the Treatment of "Steroid Dependent" Chronic Bronchial Asthmatic Patients , J Allerg 36:321, 1965;.
Seigel, S.C., et al:  Effect of Dexamethasone Aerosols in Asthmatic Children , Pediatrics 33:245, 1964;.
Dennis, M., and Itkin, I.H.:  Effectiveness and Complications of Aerosol Dexamethasone Phosphate in Severe Asthma , J Allerg 35:70, 1964;.
Bickerman, H.A., and Itkin, S.E.:  Aerosol Steroid Therapy and Chronic Bronchial Asthma , JAMA 184:533, 1963;.
Arbesman, C.E.; Bonstein, H.S.; and Reisman, R.E.:  Dexamethasone Aerosol Treatment for Bronchial Asthma , J Allerg 34:345, 1963;.
Crepea, S.B.:  Inhalation of Dexamethasone by Mouth for Asthma , J Allerg 34:119, 1963;.
Fisch, B.R., and Grater, W.C.:  Dexamethasone Aerosol in Respiratory Tract Disease , J New Drugs 2:298, 1962;.
Brown, H.M.:  Aerosol Steroids in Bronchial Asthma , Lancet 2:147, 1963;.
Liddle, G.W.:  Tests of Pituitary-Adrenal Suppressibility in the Diagnosis of Cushing's Syndrome , J Clin Endocr 20:1539, 1960;.
Linder, W.R.:  Adrenal Suppression by Aerosol Steroid Inhalation , Arch Intern Med 113: 655, 1964;.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Snider, G.L., et al:  Effect of Dexamethasone Aerosol on Airway Obstruction in Bronchial Asthma , Dis Chest 44:408, 1963;.
Toogood, J.F., and Lefcoe, N.M.:  Dexamethasone Aerosol for the Treatment of "Steroid Dependent" Chronic Bronchial Asthmatic Patients , J Allerg 36:321, 1965;.
Seigel, S.C., et al:  Effect of Dexamethasone Aerosols in Asthmatic Children , Pediatrics 33:245, 1964;.
Dennis, M., and Itkin, I.H.:  Effectiveness and Complications of Aerosol Dexamethasone Phosphate in Severe Asthma , J Allerg 35:70, 1964;.
Bickerman, H.A., and Itkin, S.E.:  Aerosol Steroid Therapy and Chronic Bronchial Asthma , JAMA 184:533, 1963;.
Arbesman, C.E.; Bonstein, H.S.; and Reisman, R.E.:  Dexamethasone Aerosol Treatment for Bronchial Asthma , J Allerg 34:345, 1963;.
Crepea, S.B.:  Inhalation of Dexamethasone by Mouth for Asthma , J Allerg 34:119, 1963;.
Fisch, B.R., and Grater, W.C.:  Dexamethasone Aerosol in Respiratory Tract Disease , J New Drugs 2:298, 1962;.
Brown, H.M.:  Aerosol Steroids in Bronchial Asthma , Lancet 2:147, 1963;.
Liddle, G.W.:  Tests of Pituitary-Adrenal Suppressibility in the Diagnosis of Cushing's Syndrome , J Clin Endocr 20:1539, 1960;.
Linder, W.R.:  Adrenal Suppression by Aerosol Steroid Inhalation , Arch Intern Med 113: 655, 1964;.

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.